Edgewise Therapeutics, Inc. (EWTX) vs Viking Therapeutics, Inc. (VKTX)

Edgewise Therapeutics, Inc. and Viking Therapeutics, Inc. are both Biotechnology companies. Edgewise Therapeutics, Inc. and Viking Therapeutics, Inc. are of similar size ($4.4B and $4.3B). Across the 8 metrics below, Edgewise Therapeutics, Inc. leads on 7 and Viking Therapeutics, Inc. on 1.

Valuation

Metric EWTX VKTX Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 9.45 10.13 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (4.70%) (13.10%) (28.84%)
Free cash flow yield (3.75%) (10.12%) (23.03%)

Profitability

Metric EWTX VKTX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (38.03%) (88.85%) (57.72%)
Return on assets (36.09%) (79.24%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EWTX VKTX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (12.41%) (215.84%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EWTX VKTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 16.24 4.72 4.73
Net debt to EBITDA 2.69 1.76 0.96

Dividend

Metric EWTX VKTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric EWTX VKTX Biotechnology median
Market cap 4.41b 4.31b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack